AC
Adicet Bio, Inc.
ACET · NASDAQ
$9.15 -1.77% (-$0.17)
1M +2.81%
Market Cap $85.5M
P/E Ratio -
Div. Yield -
ROE 74.90%
Bulios Fair Price
$8.44
7.7% downside
Trenutna cena
$9.15
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ACET trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.71x
EV/EBITDA N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 18.34%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 74.90%
ROA 66.80%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 6.71x
Int. coverage -1,219.14x
Debt/Equity 0.11x
Stability
10 /100
Unstable EPS volatility 80.28%
Profitable years 0
Beta 1.59x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ACET
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chen Schor
Employees
102
Headquarters
Boston
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report